All products are sold strictly for laboratory research use only. Not for human or veterinary consumption, diagnosis, or treatment. Not approved by the FDA.
Tesamorelin Research Peptide COA, Purity Specs & Supplier Checklist
Why Tesamorelin Documentation Matters
Tesamorelin research peptide procurement should begin with documentation, not marketing language. A qualified research buyer needs to confirm that the product page, SKU, supplier record, and available COA/specification documentation describe the same material.
This guide focuses on Tesamorelin COA review, purity documentation, HPLC/MS identity checks, and supplier transparency. It does not provide research protocols, dosing guidance, administration instructions, or medical advice.
Vespera products are sold strictly for research purposes only. They are not for human or veterinary administration, food use, cosmetic use, dietary supplementation, diagnosis, treatment, or prevention.
Tesamorelin Product Identity Fields
When reviewing a Tesamorelin research product, start with the identity fields that should be consistent across the supplier listing and internal procurement file:
Field
What to Confirm
Why It Matters
Product name
Tesamorelin 10mg
Prevents mismatched documentation
SKU
VP-TESAM-10 for Vespera Tesamorelin 10mg
Helps connect invoice, product page, and internal record
Category
Growth-Hormone Secretagogues
Supports catalog organization
Format
Lyophilized research vial
Helps align storage and handling records
COA/spec status
Available by request when documentation exists
Supports procurement review
Intended use
Research purposes only
Keeps records aligned with compliance language
What a Tesamorelin COA Should Show
A strong Tesamorelin COA or specification sheet should be product-specific. It should not look like a generic certificate that could be copied across unrelated product pages.
Important fields include:
Product name and SKU.
Lot or batch number when available.
Test date or release date.
Testing laboratory or responsible reviewer.
HPLC or UPLC purity result where available.
Mass spectrometry identity confirmation where available.
Storage or handling notes when listed.
Signature, document ID, or review field when provided.
HPLC Purity Review
HPLC and UPLC are commonly used to estimate chromatographic purity. For Tesamorelin documentation review, the purity percentage should be supported by method context, not treated as a standalone marketing claim.
Strong HPLC documentation usually shows:
A clear purity percentage.
A chromatogram or chromatogram reference.
A dominant primary peak.
Integration notes or method information when available.
Product identity that matches the SKU and product listing.
Weak HPLC documentation may show only a purity claim without analytical context.
Mass Spectrometry Identity Review
Mass spectrometry is used to support identity confirmation by comparing observed mass with the expected product identity. In a procurement workflow, MS data helps distinguish identity review from a simple purity claim.
When reviewing a Tesamorelin specification sheet, check whether:
The observed mass is listed.
The theoretical or expected mass is listed.
The product name matches the page and SKU.
The result appears tied to a batch, lot, or sample identifier.
Good vs Bad Tesamorelin Documentation
COA Element
Strong Example
Red Flag
Product name
Tesamorelin with matching SKU
Vague peptide name only
Purity
HPLC/UPLC result with method context
Percent purity with no data
Identity
MS observed/theoretical mass fields
Missing identity confirmation
Batch matching
Lot or batch number present
Generic certificate with no lot
Date
Current test or release date
Old document reused across batches
Supplier process
Clear COA request path
No documentation contact path
Step-by-Step Tesamorelin Supplier Checklist
Use this checklist before placing a procurement request:
Confirm the product page is for Tesamorelin 10mg.
Confirm the SKU is VP-TESAM-10.
Request available COA/spec documentation.
Check whether the document includes product identity fields.
Review HPLC/UPLC purity information if available.
Review mass spectrometry identity confirmation if available.
Match any lot or batch identifier to the product received.
Save the product page URL, invoice, COA, and receiving record in the same internal file.
A Tesamorelin COA is a supplier documentation record that may summarize product identity, analytical testing, purity, lot information, and release details when available.
Is a purity percentage enough?
No. A purity percentage is stronger when supported by HPLC/UPLC method context and identity confirmation, such as mass spectrometry fields.
What should I match to the vial or product record?
Match product name, SKU, strength, lot or batch identifier, and supplier record whenever those fields are available.
Does Vespera provide Tesamorelin for consumer use?
No. Vespera products are sold strictly for research purposes only and are not for human or veterinary administration.
Can I request Tesamorelin documentation?
Use the Vespera COA/spec request page to request available documentation by email as PDF attachments.
Does this guide include dosing or protocols?
No. This guide is limited to procurement documentation, COA review, supplier transparency, and research-use compliance.
Melanotan-2 Research Peptide COA, Purity Specs & Supplier Checklist
Research-Only Documentation Focus
Melanotan-2 is a research compound category where supplier language can easily drift into consumer-use claims. A serious procurement workflow should avoid those claims and focus on verifiable documentation: product identity, SKU, purity records, batch matching, and supplier transparency.
This article explains how to review Melanotan-2 COA records and specification sheets from a research procurement perspective. It does not provide protocols, dosing, administration guidance, cosmetic claims, medical claims, or consumer-use advice.
All Vespera products are sold strictly for research purposes only. They are not for human or veterinary administration, diagnosis, treatment, prevention, food use, cosmetic use, or dietary supplementation.
Product Identity Snapshot
Field
Vespera Catalog Record
Review Purpose
Product name
MT2 / Melanotan-2 (10mg)
Confirms catalog identity
SKU
VP-MT2-10
Connects invoice, product page, and internal record
Category
Other Research Compounds
Organizes procurement review
Format
Research-use peptide material
Supports controlled lab workflow
Documentation path
COA/spec request page
Creates a clear supplier contact route
What a Proper Melanotan-2 COA Should Include
A supplier COA or specification sheet should make it easy to confirm that the document applies to the product being purchased. A strong document should include:
Product name.
SKU or catalog number when available.
Lot or batch number when available.
Test date or release date.
Purity result and analytical method.
Mass spectrometry identity confirmation when available.
Reviewer, laboratory, or document identifier.
Storage or handling notes where relevant.
If a document lists only "99% purity" without method context, batch traceability, or product-specific details, treat it as a weak supplier record.
HPLC and UPLC Purity Checks
HPLC and UPLC are analytical chemistry methods used to estimate chromatographic purity. For Melanotan-2 procurement review, the key question is whether the reported purity appears tied to a product-specific analytical record.
Review the following:
Does the purity field name the method?
Is there a chromatogram or chromatogram reference?
Is the main peak clearly dominant?
Does the document identify Melanotan-2 specifically?
Does the document date make sense for the batch being reviewed?
Mass Spectrometry Identity Checks
Mass spectrometry helps support product identity by comparing observed mass with the expected identity. This matters because purity alone does not prove the material is the expected peptide.
Review the following:
Theoretical or expected mass.
Observed mass.
Product or sample identifier.
Lot or batch matching.
Any mismatch between the document and the product listing.
Supplier Red Flags
Red Flag
Why It Matters
Generic COA with no product-specific details
The document may not apply to the product being purchased
Purity claim with no analytical method
Weak evidence for procurement review
Missing mass spectrometry fields
Identity support may be incomplete
Old document reused across batches
Batch-specific traceability is unclear
Consumer-use language on supplier page
Misaligned with research-use procurement standards
No COA/spec request path
Supplier transparency is limited
Vespera Review Path
Vespera keeps the product page and documentation request workflow separate and clear:
Keep invoice, supplier documentation, and receiving notes together.
FAQ
What is a Melanotan-2 COA?
A Melanotan-2 COA is a supplier documentation record that may summarize analytical testing, purity, identity confirmation, and lot information when available.
Should researchers rely on purity claims alone?
No. Purity claims should be supported by method context and product-specific records. HPLC/UPLC and mass spectrometry fields are stronger documentation signals.
What is the main supplier red flag?
The biggest red flag is a generic COA that does not clearly match the product, SKU, lot, or batch being reviewed.
Does this article provide use guidance?
No. This article is strictly about documentation review and research procurement. It does not provide use, dosing, or administration guidance.
Where can I request Vespera documentation?
Use Request COA / Specs to request available COA/specification documents by email.
Is Melanotan-2 sold for consumer use?
No. Vespera products are sold strictly for research purposes only.
How to Read a Peptide COA: Complete Guide for Researchers (HPLC, Mass Spec, Red Flags & Batch Matching)
COA review is one of the simplest ways to separate a transparent research peptide supplier from a supplier asking buyers to trust a label with no supporting documentation. In a market full of copied product photos, generic purity claims, and recycled PDFs, a Certificate of Analysis should do more than say "98%+" in bold text. It should identify the product, connect the document to a batch or lot, show analytical data, and give the researcher enough detail to decide whether the record belongs in a procurement file.
This guide explains how to read a peptide COA without turning the document into something it is not. A COA is not medical advice, not a use protocol, and not proof of suitability for any human or veterinary application. For Vespera, peptide documentation is reviewed strictly for research purchase, vendor qualification, and analytical traceability. Products are for research purposes only.
The goal is practical: understand what a peptide COA should contain, how HPLC and mass spectrometry fit together, what a research peptide specification sheet can and cannot prove, and which red flags should stop a purchase until the supplier clarifies the record.
Quick Visual Map: What a Strong Peptide COA Should Show
Use this table as an annotated COA screenshot substitute when reviewing a PDF. A strong document does not need to look fancy, but the fields should be traceable.
COA area
What to verify
Why it matters
Header
Product name, catalog number, lot or batch number, document date, testing lab
Confirms the COA is tied to a specific product record
Identity
Sequence, molecular formula, theoretical molecular weight, observed mass
Confirms the material matches the expected peptide identity
Purity
HPLC or UPLC purity percentage, chromatogram reference, integration method when available
Estimates chromatographic purity under the listed method
Batch details
Lot number, manufacturing or release date, tested quantity or sample ID
Helps match COA to vial, invoice, or receiving record
Specification table
Test name, method, acceptance criteria, result
Shows whether each listed result meets the supplier specification
Reviewer/lab
Lab name, analyst/reviewer, signature, document number
Adds accountability and makes forgery harder
What Is a Peptide COA?
A peptide COA, or Certificate of Analysis, is a batch-level documentation record. It summarizes selected analytical tests performed on a specific peptide lot. A related document, sometimes called a research peptide specification sheet, may list expected product attributes and acceptance criteria even when batch-specific test data is limited.
For research procurement, the most useful COA connects four things:
The exact product being purchased.
The specific batch or lot represented by the document.
The analytical methods used to verify identity and purity.
The result values that support the supplier's claims.
That connection is the point. A COA that does not connect to a product and lot is not a complete procurement record, even if the purity number looks high.
Header Information Researchers Should Check First
Before reading any chromatogram or mass spectrum, start with the header. Many bad COAs fail at the first line.
Product name: The name on the COA should match the product page, label, invoice, and SKU. Small naming differences can be acceptable, but the supplier should be able to explain them. For example, a product page may say "TB-500 / Thymosin Beta-4" while the COA should specify whether the tested material is a full-length thymosin beta-4 peptide or a shorter fragment.
Lot or batch number: This is the most important traceability field. A purity result from a different lot does not verify the vial in front of you. If the COA has no lot number, request clarification.
Test date or release date: Analytical data should be recent enough to represent the batch being sold. A COA from years earlier is not automatically invalid, but it raises a reasonable question if the supplier cannot explain inventory age, retesting, or lot continuity.
Lab name: The COA should identify whether testing was done in-house, by a third-party analytical laboratory, or both. In-house testing is not automatically bad. The issue is transparency. A supplier that refuses to identify who tested the batch is asking researchers to trust an unverifiable number.
Molecular weight: Peptide COAs often list theoretical molecular weight and observed mass. These values help confirm identity when paired with mass spectrometry.
Core Tests Explained
A peptide COA is easiest to read when identity and purity are reviewed separately. HPLC helps estimate purity. Mass spectrometry helps confirm identity. A complete COA usually needs both.
HPLC Purity: What 98% or 99% Means
HPLC stands for high-performance liquid chromatography. In peptide testing, HPLC separates sample components as they pass through a column. The instrument detects peaks over time, usually using UV absorbance for peptide methods. The chromatogram is a graph of detector response against retention time.
When a COA says HPLC purity: 99.1%, that usually means the main peak represented 99.1% of the integrated chromatographic peak area under that method. It does not mean every possible impurity in the vial has been fully identified. It does not measure water content, salt form, counterions, residual solvent, net peptide content, or biological activity unless those are tested separately.
That distinction matters. A 99% HPLC purity value can still leave open questions:
Was the correct peptide identified by mass spectrometry?
Were small or co-eluting impurities resolved from the main peak?
Was the UV wavelength appropriate for the peptide?
Was the chromatogram included or only the final percentage?
Was the sample tested by a qualified lab using a documented method?
For most research peptide procurement workflows, >=98% or >=99% HPLC purity is a common supplier specification. The exact acceptance criterion should be stated on the document. A strong COA shows the criterion and the result, such as "Specification: >=98.0%; Result: 99.2%."
How to Read the Chromatogram
If the COA includes a chromatogram, look for a single dominant peak and smaller impurity peaks. You do not need to be an analytical chemist to spot obvious problems.
Review these details:
Main peak dominance: A clean chromatogram should usually show one large, well-defined main peak for the peptide under the listed method.
Retention time: The main peak should have a stated retention time. When a reference standard is used, retention time should be consistent with the reference method.
Baseline: A stable baseline makes peak integration more credible. A noisy baseline can make area percentage less reliable.
Integration marks: The chromatogram should show or report which peaks were integrated.
Unknown peaks: Small impurity peaks may be normal, but a cluster of large unknown peaks should be explained.
Method conditions: Strong reports may list column, mobile phase, gradient, flow rate, wavelength, and injection volume.
HPLC is valuable because it is a separation technique, but it is not a stand-alone identity proof. A wrong peptide can still produce a dominant chromatographic peak. That is why mass spectrometry matters.
Mass Spectrometry: Identity Confirmation
Mass spectrometry, often abbreviated MS, LC-MS, ESI-MS, or MALDI-TOF depending on the method, helps confirm molecular identity. The instrument measures mass-to-charge signals. For peptide COA review, the key comparison is usually observed mass vs theoretical mass.
A COA should make this comparison clear:
MS field
What it means
Researcher review question
Theoretical mass
Expected molecular weight from sequence/formula
Does this match the product identity?
Observed mass
Mass detected in the tested sample
Is it close enough to the theoretical value for the method?
Ion/adduct notes
Charged species or adducts observed in MS
Does the lab explain the signal format?
Spectrum image
MS trace or peak list
Is identity data visible, not only summarized?
For peptides, observed values may be shown as multiply charged ions rather than one simple molecular ion. That is normal for many LC-MS workflows. The COA or lab report should still connect the data to the expected peptide mass. If a supplier says "mass spec confirmed" but will not show any observed mass, peak list, or spectrum, that is a red flag.
Other Key Fields: Net Peptide Content, Counterions, Endotoxin, Residual Solvents
HPLC and MS are central, but they do not answer every documentation question. Depending on product type and research workflow, other fields may matter.
Net peptide content: HPLC purity is not the same as net peptide content. Lyophilized peptides can contain water, salts, counterions, and residual materials from synthesis or purification. Net peptide content estimates the actual peptide fraction by weight. When quantitative work depends on exact peptide content, this field can matter more than the headline HPLC purity.
Counterions and salt form: Peptides are commonly supplied as acetate, trifluoroacetate, hydrochloride, or another salt form. Counterions can affect molecular weight reporting, analytical interpretation, and procurement specifications. The COA should state the form when it is part of the product identity.
Endotoxin: Endotoxin testing may appear on some research material COAs. It is not a substitute for sterility and should be read only in the context of the method and acceptance criteria.
Residual solvents: Residual solvent testing may appear when a supplier documents purification or lyophilization residues. Results should be tied to a method and limit.
Appearance: A physical description such as "white lyophilized powder" is useful as a receiving check, but it is not analytical proof of identity or purity.
Storage label: Storage statements help with inventory handling, but they should not be confused with stability data unless the COA includes actual stability testing.
Step-by-Step Verification Checklist
Use this checklist when learning how to verify peptide purity COA records. It is designed for research procurement and vendor documentation review.
Confirm the product name matches the product page and invoice.
Confirm the SKU or catalog number matches the purchased item.
Match the lot or batch number on the COA to the vial label, packing slip, or order record.
Check the COA date and ask whether the document represents the current batch.
Review the HPLC purity result and acceptance criterion.
Confirm the chromatogram is included or available on request.
Review mass spectrometry identity data, including theoretical and observed mass.
Check whether the peptide sequence, formula, and molecular weight match the product identity.
Review salt form, counterion, water content, and net peptide content when listed.
Look for lab name, reviewer, document number, or signature.
Compare the COA formatting to other supplier documents for consistency.
Save the COA with the purchase record and vial lot number.
Downloadable checklist suggestion: Convert this section into a one-page PDF lead magnet titled "Peptide COA Verification Checklist for Research Buyers." Place the CTA near the top and bottom of this article: Download the Peptide COA Verification Checklist.
Supplier refuses documentation or sends unrelated COA
Red Flags and Common COA Scams
Peptide COA red flags are usually about traceability, not just numbers. A fake-looking 99.8% result is weaker than a transparent 98.6% result with a clear lot number, chromatogram, MS data, and lab report.
Generic COAs
A generic COA is a document that could apply to any batch. It may show the peptide name and a purity value but omit lot number, sample ID, test date, and lab reference. Generic COAs are not sufficient for batch verification.
Missing Mass Spectrometry
HPLC purity without MS identity data is incomplete. It may show that one major component is present, but not necessarily that the component is the correct peptide.
Old Dates With No Retest Explanation
Old dates are not automatically disqualifying, but they require context. Ask whether the supplier is selling the same lot, a retained batch, or a newer batch with an old example COA.
In-House Only Testing With No Details
In-house testing can be useful when the supplier has real analytical capability, but the COA should still show method detail and accountability. "In-house verified" with no chromatogram, no MS trace, and no analyst name is weak documentation.
Purity Claims Without Data
A product page that says "99% purity guaranteed" should be backed by a COA or a clear COA request process. Claims without data are marketing, not documentation.
Mismatched Molecular Weight
Molecular weight mismatches can happen when a salt form, adduct, hydration state, or modified residue is involved. The supplier should be able to explain the difference. If the observed mass clearly matches a different peptide or no one can explain the value, stop the review.
Reused Lab Reports
Watch for identical chromatograms across different products or batches. A repeated chromatogram image is a serious red flag unless it is clearly labeled as an example image.
How to Match a COA to Your Vial
The phrase match COA to vial research peptides means verifying that the document belongs to the actual vial received, not merely to the same product name. This is the step many buyers skip.
Check the Lot Number First
The vial label should include a lot or batch number when the supplier uses batch-level traceability. That number should appear on the COA. If the vial does not show a lot number, check the packing slip or request order-level documentation from the supplier.
Use QR Codes Carefully
QR codes can help when they lead to a secure batch documentation page. They can also be used superficially. A good QR workflow should show:
Product name.
Lot or batch number.
COA PDF or verification page.
Document date.
Supplier domain or secure file host.
If the QR code leads to a generic homepage or an unrelated PDF, it is not meaningful batch verification.
Save the Full Chain of Records
For internal procurement files, save the product page PDF or screenshot, invoice, packing slip, vial label photo, and COA together. If the supplier later changes a product page, your record still shows what was ordered and which batch was documented.
Ask Clear Questions
If a field does not match, ask the supplier direct documentation questions:
Which lot number does this COA cover?
Does this COA match the vial lot I received?
Can you provide the HPLC chromatogram and MS spectrum for this lot?
Is the listed mass for the free peptide, salt form, or observed ion?
Was testing performed in-house or by a third-party lab?
What Vespera COAs Look Like
Vespera structures research peptide documentation around batch matching, product identifiers, and transparent support. COA availability may vary by product and batch, but the review path is intentionally clear.
When reviewing Vespera documentation, researchers should expect the same core checks:
Product name and SKU.
Batch or lot reference when available.
HPLC purity or specification data when available.
Mass spectrometry identity data when available.
PDF documentation provided through a support request path.
Use this compact table in a receiving log or vendor review file.
Field
Entry
Product name
SKU/catalog number
Lot or batch number on vial
Lot or batch number on COA
HPLC purity result
MS observed mass
Theoretical mass
COA date
Lab or supplier document ID
Reviewer notes
Analytical Reference Notes
HPLC and mass spectrometry are standard analytical chemistry tools, but the quality of a COA depends on method suitability, sample handling, and traceable reporting. General analytical validation principles are reflected in documents such as ICH Q2(R2) validation of analytical procedures, which discusses analytical procedure validation, and FDA bioanalytical method validation guidance, which discusses chromatography, calibration, selectivity, accuracy, precision, and documentation expectations in regulated contexts. Research peptide supplier COAs are not the same as regulatory submissions, but the underlying principles are useful: document the method, define the acceptance criteria, and report results in a way another qualified reviewer can understand.
Conclusion
Learning how to read a peptide COA is not about memorizing one purity number. It is about checking whether the document proves the right product, the right batch, and the right analytical evidence. Strong COAs connect product identity, HPLC purity, mass spectrometry, lot traceability, and document control in one clear record.
For research buyers, transparency is the trust signal. Request batch-matched documentation, compare the COA to the vial, and avoid suppliers that rely on generic PDFs or unsupported purity claims.
A peptide COA is a Certificate of Analysis that summarizes selected analytical results for a specific peptide batch or lot. It may include product identity, HPLC purity, mass spectrometry data, molecular weight, test date, and supplier or lab information.
How do I verify peptide purity on a COA?
Check the HPLC purity result, method label, acceptance criterion, and chromatogram. Then confirm the COA also includes identity data such as mass spectrometry. Purity alone does not prove the peptide is the correct identity.
What does 99% HPLC purity mean?
It usually means the main chromatographic peak represents 99% of the integrated peak area under the listed HPLC method. It does not automatically measure net peptide content, water, salts, counterions, or every possible impurity.
Why is mass spectrometry important on a peptide COA?
Mass spectrometry helps confirm identity by comparing observed mass to theoretical mass. A strong COA uses HPLC for purity and MS for identity rather than relying on only one test.
What are common peptide COA red flags?
Common red flags include missing lot numbers, generic PDFs, no MS data, no chromatogram, old dates without explanation, anonymous lab reports, and purity claims without supporting data.
How do I match a COA to a vial?
Compare the product name, SKU, and lot or batch number on the COA with the vial label, packing slip, or order record. If the lot does not match, ask the supplier for the correct batch-specific document.
Is a COA the same as a specification sheet?
No. A COA is usually batch-specific and reports results. A specification sheet may list expected attributes, methods, and acceptance criteria. Both can be useful, but they answer different documentation questions.
Does a COA provide use instructions?
No. A COA is an analytical and procurement document. It does not provide dosing, administration, medical guidance, or suitability for human or veterinary use. Vespera products are strictly for research purposes only.
Semax and Selank Research Peptides: Documentation, Purity Specs & Quality Checklist (2026 Guide)
Semax and Selank are often searched together because both are short neuropeptide research materials with origins in Russian peptide research programs. For a research supplier, the safest and most useful way to compare them is not through consumer claims or protocol language. It is through documentation: sequence identity, molecular weight, purity testing, mass spectrometry confirmation, storage labeling, and batch-matched COAs.
This guide explains how to review Semax COA and Selank specifications from a procurement perspective. It is intended for researchers and lab buyers comparing documentation quality, not for personal use, dosing, diagnosis, treatment, or outcome guidance. Vespera products are strictly for research purposes only.
If you are comparing Semax vs Selank suppliers, start with the same question for both peptides: can the supplier connect the product page, vial label, lot number, HPLC purity data, and mass spectrometry identity data in one traceable record?
Peptide Identity and Specs
Short peptides can look deceptively simple on a product page. A complete research record should still identify the sequence, molecular weight basis, salt form when applicable, and batch-level analytical results.
Semax Identity Snapshot
Semax is commonly described as an ACTH(4-10) analog with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, often abbreviated MEHFPGP. Public chemical references commonly list the free peptide molecular weight around 813.9 Da, while supplier documents may show a different apparent value if a salt form, counterion, hydration state, or analytical ion is being reported.
For COA review, do not rely on the name alone. A Semax research peptide documentation record should state:
Product name: Semax.
Sequence: MEHFPGP, or the supplier's full written sequence.
Theoretical molecular weight and the basis for that value.
Selank is commonly described as a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, often abbreviated TKPRPGP. Public chemical references commonly list the free peptide molecular weight around 751.9 Da. As with Semax, the value on a supplier COA should be read in context: free peptide, salt form, observed ion, and report format can affect how mass is displayed.
A strong Selank purity research record should state:
Product name: Selank.
Sequence: TKPRPGP, or the supplier's full written sequence.
The table below is designed for research procurement, not use guidance.
Field
Semax
Selank
What to verify
Common sequence notation
MEHFPGP
TKPRPGP
Sequence should appear on supplier specification records
Typical length
7 amino acids
7 amino acids
Count should match the reported sequence
Approximate free peptide MW
About 813.9 Da
About 751.9 Da
COA should explain salt form or observed ion differences
Research category
Neuropeptide and ACTH-fragment research context
Neuropeptide and regulatory peptide research context
Supplier copy should stay research-only
Common documentation tests
HPLC purity and MS identity
HPLC purity and MS identity
Both tests should be batch traceable
Stability review
Short peptide, storage depends on format and supplier label
Short peptide, storage depends on format and supplier label
Follow documented storage label, not generic forum advice
Study protocol reporting
Original studies vary by model and design
Original studies vary by model and design
Supplier pages should not provide dosing instructions
The most important comparison is not which peptide has a more appealing marketing description. It is whether the supplier can produce batch-matched documentation that supports the exact vial, SKU, and lot being reviewed.
What Researchers Usually Want to Know Before Reviewing a Semax or Selank Supplier
Clinic-style peptide pages are often easy to read because they answer practical questions in a direct order: what the product is, how it differs from related products, what a buyer should check, and what questions come up most often. Vespera should use that clarity, but with research-only boundaries.
For Semax and Selank, the safer research-supplier version of that structure looks like this:
Buyer question
Vespera-safe answer format
What is it?
Sequence, molecular weight basis, product identity, and research category
How is Semax different from Selank?
Documentation comparison by sequence, MW, identity method, and supplier record
What should I verify?
HPLC purity, MS identity, lot number, COA date, and SKU match
What makes a supplier credible?
Batch-matched COA access, transparent support, and consistent product labels
What should I avoid?
Generic COAs, unsupported purity claims, missing MS, and use/outcome claims
This keeps the page useful for real buyers without publishing dosing instructions, administration guidance, or consumer outcome claims.
Research-Only Product Page Sections That Work
For Semax and Selank product and article pages, the strongest sections are:
Identity snapshot: sequence, molecular weight, product name, SKU, and format.
Documentation checklist: COA, HPLC, MS, batch number, and document date.
Comparison table: Semax vs Selank by analytical and catalog fields.
Supplier questions: what to ask before accepting a COA.
FAQ: concise answers about documentation, purity, mass spec, and lot matching.
Sections to avoid on a research peptide supplier site include user benefits, candidate profiles, expected effects, cycle length, dose ranges, nasal spray administration, and side-effect management. Those topics shift the page away from procurement documentation and into use guidance.
What a Proper COA Should Show
Semax and Selank COAs should follow the same core standard as other research peptide documentation: identity, purity, traceability, and method clarity.
Expected HPLC/MS Fields
A proper COA should show:
Product name and SKU.
Lot or batch number.
Test date or release date.
HPLC purity result, ideally with chromatogram.
Mass spectrometry identity confirmation.
Theoretical molecular weight.
Observed molecular weight or ion series.
Acceptance criteria, such as >=98.0% or >=99.0% HPLC purity when used by the supplier.
Lab name, reviewer, or document ID.
For Semax and Selank, a reported purity threshold of >=98% or >=99% by HPLC is common in research supplier catalogs. The number should be attached to the method and batch. A product page claim is weaker than a PDF that shows lot number, HPLC chromatogram, and MS data.
How to Read the HPLC Result
An HPLC result estimates chromatographic purity under the listed method. In practical terms, researchers should look for one dominant main peak, a stable baseline, and minor impurity peaks that are clearly separated and integrated.
For short peptides like Semax and Selank, chromatographic conditions matter. A poor method can make impurities appear cleaner than they are, especially if peaks are not well resolved. The COA should not merely say "99% pure"; it should show enough context to make the claim reviewable.
How to Read the Mass Spec Result
Mass spectrometry helps answer the identity question: does the sample match the expected peptide mass? The report may show a molecular ion, charged species, or a deconvoluted mass depending on the instrument and method. The supplier should be able to explain the observed value in relation to the theoretical value.
When reviewing Semax research peptide documentation or Selank purity research records, ask:
Does the observed mass align with the expected sequence?
Is the mass value for the free peptide, salt form, or observed ion?
Is the spectrum included or available on request?
Does the lab report identify the sample or batch?
Red Flags Specific to Semax and Selank
Semax and Selank are relatively short peptides, which makes vague supplier documentation harder to justify. Watch for these red flags:
Red flag
Why it matters
No sequence listed
Short peptides should be easy to identify by sequence
HPLC purity only, no MS
Purity does not prove identity
Product page says "98%+" but no batch COA is available
Marketing claim is not a procurement record
Same COA reused for Semax and Selank
Different sequences require separate identity data
No lot number on vial or document
COA cannot be matched to the received material
Therapeutic or consumer-use claims
Research supplier copy should remain research-only
Unexplained mass mismatch
Could reflect salt form, adduct, or wrong identity and must be clarified
Quality Checklist for Semax and Selank Research Peptides
Use this checklist before accepting Semax or Selank documentation for a procurement file.
Batch Matching
Confirm the product name on the COA matches the vial label.
Confirm the lot number on the vial matches the COA.
Save a copy of the product page, invoice, and COA together.
Ask the supplier to confirm whether the COA is for the current lot.
Identity Review
Confirm the sequence appears on the COA or specification sheet.
Confirm the theoretical molecular weight is listed.
Confirm MS identity data is included or available.
Review whether the supplier reports free peptide, acetate, TFA, HCl, or another salt form.
Purity Review
Confirm HPLC or UPLC purity is listed.
Review whether the acceptance criterion is stated.
Look for a chromatogram or supporting HPLC report.
Avoid relying on "lab tested" language without data.
Storage and Handling Notes
Storage notes should come from the supplier label or specification sheet. For lyophilized research peptides, many suppliers provide temperature and light exposure guidance, but storage language is not a substitute for stability testing. If stability matters for your research workflow, request stability documentation or confirm how the supplier defines shelf-life.
Do not treat supplier storage notes as instructions for human or veterinary use. Vespera products are research materials only.
Supplier Questions for Semax and Selank Procurement
Use specific documentation questions when contacting a supplier. These questions are more useful than broad claims about quality.
Can you provide the batch-specific Semax or Selank COA for the current lot?
Does the COA include both HPLC purity and MS identity data?
Is the molecular weight listed for the free peptide, salt form, or observed MS ion?
Does the vial lot number match the COA lot number?
Can you provide the HPLC chromatogram if it is not already included?
Was the analysis performed in-house, by a third-party lab, or both?
Are Semax and Selank documented separately if they are listed as a paired product or blend?
For any Semax/Selank blend listing, ask whether the supplier can document each component identity and the blend batch record. A blend name is not a substitute for component-level analytical evidence.
Semax and Selank Blend Documentation
Some buyers search for Semax and Selank together because paired listings are common in the broader peptide market. For a research supplier, a blend or paired product requires more documentation, not less.
If a listing describes a Semax/Selank blend, researchers should verify:
The exact amount or ratio of each component if the product is a true blend.
Separate identity support for Semax and Selank.
A batch record for the finished blend.
HPLC method suitability for resolving both components and related impurities.
MS identity data for each peptide or a clear validated approach for the blend.
Lot number matching between product label, COA, and order record.
If Semax and Selank are sold as separate products, each should have its own COA/spec record. Do not assume that a COA for one peptide says anything about the other.
Downloadable Checklist Suggestion
Suggested lead magnet: Semax and Selank COA Review Checklist for Research Buyers.
When requesting documents, include product name, SKU, order number or purchase email, and lot number if available. This helps match the request to the correct batch record.
Analytical Reference Notes
COA review should be grounded in general analytical chemistry principles. HPLC separates components and estimates chromatographic purity. Mass spectrometry compares observed mass signals with theoretical peptide mass. Public chemical records such as PubChem Semax and PubChem Selank can be useful cross-checks for formula and mass context, while supplier COAs should still control batch-specific review. Analytical validation frameworks such as ICH Q2(R2) emphasize method characteristics like specificity, accuracy, precision, and range. FDA bioanalytical guidance also highlights documentation expectations for chromatographic and mass spectrometric methods in regulated analytical contexts. Research peptide COAs are not regulatory filings, but the same logic applies: state the method, show the result, and make the record traceable.
Conclusion
Semax and Selank are best compared through documentation quality: sequence identity, molecular weight basis, HPLC purity, mass spectrometry confirmation, and lot-level traceability. A clean supplier record should let a researcher connect the product page, vial, batch number, and COA without guessing.
For reproducible research procurement, do not accept generic PDFs or unsupported purity claims. Request batch-matched documentation, save the COA with your receiving records, and use transparent suppliers that make verification easy.
A Semax COA should include product name, sequence or identity reference, lot number, HPLC purity result, mass spectrometry identity data, theoretical and observed molecular weight, test date, and lab or supplier document details.
What are Selank specifications?
Selank specifications usually include product identity, sequence, molecular weight, purity acceptance criteria, appearance, storage label, and batch documentation fields. A batch COA should report actual test results for the lot.
What is the main Semax vs Selank documentation difference?
The sequences differ: Semax is commonly listed as MEHFPGP, while Selank is commonly listed as TKPRPGP. Because they are different peptides, each should have separate identity and purity documentation.
Is HPLC purity enough to verify Semax or Selank?
No. HPLC purity estimates chromatographic purity under the listed method. Mass spectrometry is needed to help confirm peptide identity.
What purity threshold should I look for?
Many research suppliers list >=98% or >=99% HPLC purity for Semax and Selank. The threshold should appear with an actual batch result, method label, and ideally chromatogram support.
Why might molecular weight differ between sources?
Differences can reflect free peptide vs salt form, counterions, hydration, adducts, or whether the report shows a charged MS ion. Ask the supplier to explain the basis for the listed value.
Does this guide provide dosing or use instructions?
No. This guide is strictly for research procurement and documentation review. It does not provide dosing, administration, medical advice, or consumer-use guidance.
How can I request Vespera Semax or Selank documentation?
Use the COA / Specs Request page and include the product name, SKU, order details, and lot number if available.
BPC-157, TB-500 & GHK-Cu Research Peptides: COA Review, Purity Specs & Quality Checklist
BPC-157, TB-500, and GHK-Cu are often discussed together in regenerative, tissue-model, and copper peptide research contexts. Search behavior sometimes groups them under phrases like "healing stack" or "Glow stack COA," but a research supplier should not treat those marketing labels as scientific documentation. For procurement and reproducibility, each peptide must be reviewed by exact identity, sequence, molecular weight basis, HPLC purity, mass spectrometry confirmation, and batch traceability.
This guide explains how to review BPC-157 COA, TB-500 specifications, and GHK-Cu purity research records without drifting into consumer-use claims. It is intended for researchers and lab buyers who need documentation quality, not dosing, administration, medical guidance, or outcome promises. Vespera products are strictly for research purposes only.
The key principle is simple: popular peptide clusters should not be purchased on popularity. They should be evaluated through traceable COAs and specification records.
Individual Peptide Profiles
The identity section is where many weak supplier pages create confusion. A product name is not enough. A research peptide documentation record should specify the exact molecule being sold.
BPC-157: Sequence, Molecular Weight, and Research Context
BPC-157 is commonly listed as a 15-amino-acid peptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, abbreviated GEPPPGKPADDAGLV. Public chemical references commonly list a molecular weight around 1419.5 Da for the free peptide.
For BPC-157 research peptide documentation, verify:
Sequence: GEPPPGKPADDAGLV.
Theoretical molecular weight and salt form.
Observed mass from MS or LC-MS.
HPLC purity result and chromatogram.
Lot or batch number.
COA date and testing lab.
The COA should not rely only on a product name. BPC-157 is frequently marketed in inconsistent ways, and the only useful procurement record is one that ties the exact sequence and batch to analytical data.
TB-500: Sequence, Molecular Weight, and Naming Caution
TB-500 documentation requires extra attention because naming varies across supplier catalogs. Some catalogs use TB-500 to refer to the short N-acetylated thymosin beta-4 fragment commonly written Ac-LKKTETQ. Other suppliers use TB-500 or "Thymosin Beta-4" to refer to the full-length 43-amino-acid thymosin beta-4 sequence. These are not the same analytical identity.
For that reason, a TB-500 COA should state exactly what was tested:
Product name and synonym.
Full sequence or fragment notation.
Whether the material is a short fragment or full-length thymosin beta-4.
Theoretical molecular weight for that exact identity.
Observed mass by MS or LC-MS.
HPLC purity result.
Lot or batch number.
If a supplier shows a molecular weight near the short fragment range while the product is described as full-length thymosin beta-4, or vice versa, request clarification before accepting the record.
GHK-Cu: Copper Peptide Identity and Molecular Weight Caveats
GHK-Cu refers to a copper complex of the tripeptide Gly-His-Lys. The underlying peptide sequence is GHK, but the copper complex, protonation state, counterions, and salt form affect how molecular weight and formula may be reported. Public chemical references commonly place copper tripeptide values around the low 400 Da range depending on the represented ion or salt.
For GHK-Cu purity research documentation, verify:
Whether the document identifies GHK-Cu as a copper complex, not only the free GHK peptide.
Formula and molecular weight basis.
Copper content or complex identity when reported.
HPLC or related purity method.
MS identity data when suitable for the method.
Lot number and COA date.
GHK-Cu is a useful example of why a headline purity percentage is not enough. The identity question includes the peptide and the metal complex. A specification sheet should make that distinction clear.
Comparison Table: Applications, Stability, and Research Pairings
This table is framed for research taxonomy and procurement review. It is not a protocol or use guide.
Peptide
Identity point
Common research context language
Documentation concern
Batch review priority
BPC-157
15-aa peptide, GEPPPGKPADDAGLV
Tissue-model, cytoprotective, pathway research references
Confirm sequence and salt form
HPLC purity plus MS identity
TB-500
Naming may mean fragment or full-length thymosin beta-4
Thymosin beta-4 and actin-related research references
Confirm exact sequence and MW
Resolve fragment vs full-length identity
GHK-Cu
Copper complex of Gly-His-Lys
Copper peptide and matrix-model research references
Confirm complex, not only free GHK
Identity, copper complex notation, purity
Common Research Pairing Language
Supplier pages often use cluster language because buyers search for related peptides together. That can be acceptable for navigation, but it should not replace component-level documentation. If a product page or bundle mentions BPC-157, TB-500, and GHK-Cu together, each component should still have its own identity and batch record.
For blend terminology, including phrases like Glow stack COA, researchers should verify:
Whether the product is actually a blend or simply a category grouping.
Whether each component has a separate COA.
Whether the blend has its own batch record.
Whether the COA reports component identity and ratios, if applicable.
Whether the supplier avoids medical or cosmetic claims.
COA and Documentation Deep Dive
A strong COA for these peptides should cover identity, purity, and traceability. Because each peptide has different identity risks, the review emphasis changes slightly.
BPC-157 COA Review
For BPC-157, start by confirming the 15-amino-acid sequence. Then review HPLC purity and mass spectrometry.
BPC-157 field
Strong record
Weak record
Sequence
GEPPPGKPADDAGLV listed
Sequence missing
Molecular weight
Theoretical MW listed with basis
Only product name shown
HPLC
Purity result plus chromatogram
"99% pure" text only
MS
Observed mass matches expected identity
No MS data
Batch
Lot number on COA and vial
No traceable lot
TB-500 Specifications Review
TB-500 requires a nomenclature check before purity review. A high purity value for the wrong identity is still the wrong product record.
Questions to ask:
Does the COA identify the product as TB-500, thymosin beta-4, or a fragment?
Is the sequence shown?
Does the molecular weight align with the stated identity?
Is the MS result consistent with the stated sequence?
Does the vial label use the same product name as the COA?
If any of these answers are unclear, ask the supplier for a corrected specification sheet.
GHK-Cu Purity Review
For GHK-Cu, the main issue is whether the document confirms the copper complex and not just the tripeptide. Depending on method, HPLC may be used for peptide-related purity, while additional assays may be needed to characterize copper content or complexation. The COA should make clear what each test does and does not measure.
Recommended fields:
Product name: GHK-Cu or copper tripeptide.
Sequence: GHK.
Formula or molecular weight basis.
Copper complex notation.
HPLC or UPLC purity result.
MS or identity confirmation when applicable.
Lot number and document date.
Purity Expectations and Analytical Tests
For research peptide suppliers, 98%+ HPLC purity is a common specification claim. Some suppliers target >=99%. The threshold matters less than whether the supplier provides real batch data.
HPLC or UPLC Purity
HPLC separates sample components and estimates purity based on peak area under the stated method. UPLC is a related high-efficiency chromatographic approach. In both cases, a result should be read with:
Method label.
Chromatogram.
Acceptance criterion.
Main peak retention time.
Integration notes when available.
Mass Spectrometry Identity
MS or LC-MS should compare observed mass to theoretical mass. For BPC-157 and TB-500, this is especially important because sequence identity is central. For GHK-Cu, identity interpretation may require more context because metal complexes and ions can be reported differently.
Net Peptide Content
Net peptide content is distinct from chromatographic purity. It can be important for quantitative research records because lyophilized material can include salts, water, and counterions. If exact content matters, request the supplier's net peptide content or assay method.
Residual Solvents and Counterions
Peptide synthesis and purification can leave residual solvents or counterions. A specification sheet may list acetate, TFA, HCl, or other forms. Do not assume all versions of the same peptide are analytically identical.
Red Flags and Verification Checklist
Red Flags
Red flag
Why it matters
BPC-157 COA lacks sequence
The identity cannot be reviewed
TB-500 COA omits fragment vs full-length status
The product identity may be ambiguous
GHK-Cu COA does not mention copper complex
The document may describe only GHK
Same chromatogram appears across multiple products
Possible recycled documentation
No lot number
Cannot match COA to vial
No mass spec data
Identity confirmation is incomplete
Medical, healing, cosmetic, or recovery claims
Research supplier copy should remain documentation-focused
Purity claim without chromatogram
The number is not independently reviewable
Verification Checklist
Confirm the product page name and vial label match.
Confirm the SKU and strength match the order.
Confirm the lot number on the COA matches the vial or packing slip.
Confirm the sequence or exact identity is listed.
Confirm HPLC or UPLC purity is shown with an acceptance criterion.
Confirm MS identity data is included or available.
Confirm molecular weight aligns with the exact identity and salt form.
Confirm the document date is reasonable for the batch.
Save the COA with the invoice and receiving record.
Reject or escalate records with unsupported claims or mismatched identity fields.
Practical Review Workflow for a Receiving Team
For a research buyer, the review should be repeatable. The same workflow can be used whether the material is one BPC-157 vial, a TB-500 order, a GHK-Cu order, or a grouped purchase containing all three.
Step 1: Build the Product Record
Start with the supplier-facing record. Save the product page or catalog entry showing the name, SKU, listed format, and research-use-only language. If the product page uses a broad phrase such as "regenerative research peptide," do not treat that phrase as the identity. Identity comes from sequence, formula, and analytical documentation.
Step 2: Match the Received Item
When the material arrives, compare the vial label with the order record. Record product name, SKU, lot number, quantity or vial size, and any storage label. This receiving check is basic, but it prevents a common documentation failure: saving a COA that belongs to a different SKU or a different lot.
Step 3: Review Identity Before Purity
Purity is only meaningful after identity is clear. For BPC-157, confirm the 15-amino-acid sequence. For TB-500, resolve whether the product is the short fragment or full-length thymosin beta-4. For GHK-Cu, confirm that the copper complex is documented. Only then should the HPLC purity number be accepted as relevant to the product.
Step 4: Review Analytical Data
Read HPLC and MS together. HPLC estimates chromatographic purity under the listed method; MS helps confirm that the dominant material matches the expected mass. If a supplier provides only HPLC, request MS. If a supplier provides only MS, request purity data. A credible research supplier should understand why both questions matter.
Step 5: Archive the Record
Save the COA, product page, invoice, packing slip, and label photo in the same internal folder. Name the file with product and lot number, such as BPC-157_VP-BPC-5_Lot-XXXX_COA.pdf. Clear file naming makes later vendor review easier and reduces the chance of mixing records between product clusters.
Downloadable Checklist Suggestion
Suggested PDF: BPC-157, TB-500 and GHK-Cu COA Review Checklist.
When requesting documentation, include the product name, SKU, order number or purchase email, and lot number if available. For TB-500, include any question about fragment vs full-length identity directly in the notes field.
Supplier Questions That Keep the Review Documentation-Focused
The best supplier questions are precise and avoid use claims. Use language like this:
Can you confirm whether this TB-500 lot is a short fragment or full-length thymosin beta-4?
Can you provide the HPLC chromatogram for this BPC-157 batch?
Does the GHK-Cu specification sheet identify copper complexation or only the GHK peptide?
Is the molecular weight listed for the free peptide, salt form, or observed MS ion?
Does the COA match the lot number printed on the vial?
Was the analysis performed in-house, by a third-party lab, or both?
Avoid asking suppliers for protocol, administration, or outcome guidance. A transparent supplier should answer documentation questions clearly and keep the conversation within research-use-only boundaries.
Analytical Reference Notes
General analytical chemistry principles support this review process. HPLC and UPLC are separation methods used to estimate chromatographic purity. Mass spectrometry supports identity by comparing observed mass signals with theoretical mass. Public records such as PubChem BPC-157, PubChem thymosin beta-4, and PubChem copper tripeptide can help reviewers understand formula and mass context, but batch-specific supplier records still control procurement review. ICH Q2(R2) provides a widely recognized framework for analytical procedure validation concepts such as specificity, accuracy, precision, and range. FDA bioanalytical method validation guidance discusses chromatographic and mass spectrometric documentation in regulated settings. Research peptide COAs are supplier records, not regulatory approvals, but transparent methods and traceable results remain the standard for credible documentation.
Conclusion
BPC-157, TB-500, and GHK-Cu are high-interest research peptides, but high interest does not reduce the need for documentation. A supplier should be able to show what the product is, which batch was tested, how purity was measured, and how identity was confirmed.
For BPC-157, sequence confirmation is central. For TB-500, exact naming and molecular weight are critical because fragment and full-length terminology can be confused. For GHK-Cu, the copper complex must be documented clearly. Across all three, batch-matched COAs are the trust signal.
A BPC-157 COA should show product name, sequence, lot number, HPLC purity, mass spectrometry identity data, theoretical and observed molecular weight, test date, and lab or supplier document details.
What are TB-500 specifications?
TB-500 specifications should identify whether the product is a short thymosin beta-4 fragment or full-length thymosin beta-4, then list sequence, molecular weight basis, purity method, identity method, and batch information.
Why is TB-500 naming a red flag?
Supplier catalogs use TB-500 terminology inconsistently. Some mean a short fragment, while others mean full-length thymosin beta-4. The COA must specify the exact tested identity.
What should a GHK-Cu COA include?
A GHK-Cu COA should identify the product as a copper complex of GHK, list formula or molecular weight basis, report purity or assay results, and provide lot-level traceability.
Is 98% HPLC purity enough?
No. A 98%+ HPLC result is useful, but it should be paired with identity confirmation by MS or another suitable method and should match the exact batch.
How do I review a Glow stack COA?
First determine whether the product is a true blend or a marketing bundle. Each component should be identifiable, batch traceable, and supported by COA/spec documentation. Avoid records that hide component identity behind blend language.
Does this article discuss healing or recovery use?
No. This article is strictly for research procurement and analytical documentation review. It does not provide medical advice, dosing, administration instructions, or consumer-use claims.
How can I request Vespera COAs?
Use the COA / Specs Request page and include product name, SKU, order details, and lot number if available.
GLP-1-related research peptides sit in one of the highest-demand areas of the peptide market. That demand creates a documentation problem: more listings, more copied product pages, more unsupported purity claims, and more confusion between research-grade materials, regulated medicines, and gray-market marketing language. For researchers and procurement teams, the safest way to evaluate this category is through documentation, not hype.
This guide explains how to review tirzepatide research COA records, semaglutide research peptide specifications, and broader GLP-1 research peptides documentation. It does not provide medical advice, dosing guidance, administration instructions, or consumer-use claims. Vespera products are strictly for research purposes only.
For high-demand GLP-1 search terms, supplier trust should be built from product identity, HPLC purity, mass spectrometry, batch matching, and transparent COA access. A supplier that cannot document the material should not ask researchers to rely on the label.
Identity and Specs: Tirzepatide vs Semaglutide
GLP-1-related peptides are structurally more complex than many short research peptides. They include modified residues, fatty-acid side chains, linkers, and sequence-specific identity markers. A simple product name is not enough for procurement review.
Tirzepatide Research Peptide Identity
Tirzepatide is commonly described in public chemical references as a 39-amino-acid synthetic peptide conjugated to a C20 fatty diacid moiety. Public databases commonly list a formula of C225H348N48O68 and molecular weight around 4813 Da for the represented structure. Because tirzepatide contains non-standard and modified elements, a supplier COA should not rely only on a plain one-letter peptide sequence.
For research-grade tirzepatide purity review, a specification record should state:
Product name: Tirzepatide.
SKU or catalog number.
Modified sequence or structural description.
Molecular formula and theoretical molecular weight.
Semaglutide is commonly described as a 31-amino-acid GLP-1 analog with a fatty-acid side-chain modification. Public chemical references commonly list a formula of C187H291N45O59 and molecular weight around 4113.6 Da for the represented structure. Supplier records may show sequence notation with Aib and a lysine-linked side chain, or a structural descriptor rather than a simple unmodified peptide sequence.
For semaglutide research peptide specifications, look for:
Product name: Semaglutide.
SKU or selected strength.
Modified sequence or structural descriptor.
Molecular formula and theoretical molecular weight.
For short unmodified peptides, sequence plus molecular weight often gets the reviewer most of the way to identity. For GLP-1 research peptides, modified residues and lipidated side chains make that less simple. A COA should clearly state what molecule was tested and how the analytical method confirms it.
If a document gives only "Tirzepatide, 99%" or "Semaglutide, 98%+" without formula, mass spec, lot number, or method context, it is not a strong procurement record.
COA Requirements Specific to GLP-1 Research Peptides
GLP-1 research peptides deserve higher scrutiny because demand is high and the molecules are more complex. Documentation should be stronger, not weaker.
HPLC or UPLC Purity
HPLC and UPLC are commonly used to estimate chromatographic purity. A GLP-1 COA should report:
Purity result, such as 98.5% or 99.1%.
Acceptance criterion, such as >=98.0%.
Method label.
Chromatogram or supporting report.
Main peak retention time.
Integration details when available.
For GLP-1 peptides, the method must resolve closely related impurities. A high purity number without chromatographic evidence is a weak claim. If the chromatogram is missing, request it.
Mass Spectrometry Identity
Mass spectrometry is critical for identity confirmation. Tirzepatide and semaglutide include modifications that should be reflected in theoretical mass. A strong report compares observed mass to theoretical mass and identifies the sample or lot.
Review these questions:
Is the expected formula or theoretical mass listed?
Is observed mass shown?
Is the MS method identified?
Does the report show a spectrum or deconvoluted mass?
Is the sample ID linked to the same lot number as the product?
Impurity Scrutiny
GLP-1 research peptide impurities may include deletion sequences, truncated sequences, side-chain-related impurities, oxidation products, synthesis byproducts, counterions, or residual solvent traces. A supplier COA may not identify every impurity, but it should at least show purity method and result. More advanced supplier documentation may include related substances, residual solvents, water content, or assay fields.
Researchers should be cautious with suppliers that advertise extreme purity without showing how impurities were measured.
Net Peptide Content and Assay
For quantitative workflows, net peptide content and assay can matter. HPLC purity estimates chromatographic purity among detected peaks, while net peptide content may account for water, salts, and counterions. If your procurement process requires accurate content records, ask whether the supplier can provide assay or net peptide content data.
Counterions, Salt Form, and Water Content
Peptides may be supplied with counterions or salts depending on synthesis and purification. GLP-1 analogs can also have complex side-chain structures. The specification sheet should make clear whether molecular weight and formula refer to the base peptide, salt form, or represented active structure.
Tirzepatide vs Semaglutide: Specs and Documentation Only
This table compares supplier documentation fields only. It does not compare medical use, dose, outcomes, or human applications.
Field
Tirzepatide
Semaglutide
What researchers should verify
Research category
GLP-1/GIP-related peptide research reference
GLP-1-related peptide research reference
Supplier copy should remain research-only
Approximate represented MW
About 4813 Da
About 4113.6 Da
COA should state formula/mass basis
Structural complexity
39-aa synthetic peptide with C20 fatty diacid moiety
31-aa GLP-1 analog with fatty-acid side-chain modification
Modified sequence or structural descriptor should be included
Core purity test
HPLC or UPLC
HPLC or UPLC
Result should include method and acceptance criterion
Core identity test
MS or LC-MS
MS or LC-MS
Observed mass should align with expected identity
Batch traceability
Lot number on COA and vial/order
Lot number on COA and vial/order
COA must match the received batch
Supplier red flag
Generic COA for "GLP-1"
Generic COA for "GLP-1"
Product-specific records are required
How to Evaluate Suppliers
The phrase tirzepatide supplier COA should mean more than a PDF on a product page. It should mean a supplier can demonstrate traceability from order to vial to batch documentation.
Supplier Documentation Checklist
Use this checklist when comparing GLP-1 research suppliers.
Product page identifies the peptide clearly.
SKU or catalog number is visible.
Product page avoids medical, dosing, or consumer-use claims.
COA request path is easy to find.
COA includes product name and lot number.
HPLC or UPLC purity is reported with method context.
Mass spectrometry identity data is included.
Molecular weight or formula matches the represented structure.
COA date and lab/report reference are visible.
Supplier can explain salt form, counterion, or mass notation.
Good vs Bad GLP-1 Supplier Documentation
Supplier element
Strong
Weak
Product identity
Tirzepatide or Semaglutide named with SKU and structural notes
Generic "GLP-1 peptide" language
COA access
Batch-specific PDF available or requestable
No COA path or only screenshots
HPLC data
Result plus chromatogram
Purity claim only
MS data
Observed vs theoretical mass
No identity confirmation
Lot matching
COA lot matches vial/order
Same COA used for all batches
Compliance
Research-only procurement framing
Human-use claims or dosing instructions
Transparency
Supplier explains method and mass caveats
Supplier refuses technical questions
Questions to Ask Before Ordering
Ask direct, documentation-focused questions:
Can you provide the COA for the current tirzepatide lot?
Does the semaglutide COA include LC-MS or MS identity data?
What HPLC or UPLC purity method is listed?
Does the COA match the lot number on the vial?
Is the listed molecular weight for the represented peptide structure or a salt form?
Are COA/spec PDFs provided before or after purchase?
If the supplier cannot answer basic documentation questions, treat that as a procurement risk.
Compound-Specific Red Flags
GLP-1 documentation failures are often subtle because the product names are familiar. Familiarity can make a weak COA look more credible than it is. Reviewers should separate brand recognition from analytical proof.
Tirzepatide Red Flags
Treat these as escalation points:
A COA lists only "Tirzepatide 99%" with no structural descriptor, formula, or mass data.
The document does not mention GLP-1/GIP-related identity or modified peptide structure.
The molecular weight does not align with the represented tirzepatide structure and no explanation is provided.
The supplier uses one COA for multiple strengths or lots without explaining batch commonality.
The product page includes dosing, administration, or consumer outcome language instead of research-use procurement language.
Semaglutide Red Flags
For semaglutide, watch for:
Product-specific name missing from the COA.
No MS or LC-MS identity confirmation.
HPLC purity claim without chromatogram or method label.
Confusion between semaglutide, semaglutide sodium salt, and unrelated GLP-1 analogs.
No lot number on the vial or document.
Product copy that shifts from research documentation into medical or weight-related claims.
The safest response to any red flag is not to infer the answer. Request clarification and keep the procurement record open until the supplier provides a documented explanation.
How to Match GLP-1 COAs to Vials
Batch matching is especially important in high-demand categories because suppliers may sell through lots quickly.
Match the Name
Confirm the COA says Tirzepatide or Semaglutide exactly. Do not accept a generic incretin or GLP-1 document for a product-specific record.
Match the SKU
If the product has selectable strengths, confirm the SKU or parent product record. Variable products may share a parent SKU but have strength-specific variation SKUs.
Match the Lot
The lot number on the vial, label, packing slip, or supplier record should match the COA. If the lot number is not visible, request order-specific documentation.
Match the Date
The test date should make sense for the batch. If a supplier provides an old COA for a current vial, ask whether the lot is still the same and whether retesting exists.
Save the Record
Store the COA with the invoice, product page copy, and receiving notes. For research procurement, a complete documentation trail is more useful than a screenshot saved without context.
Procurement Scenario: Comparing Two GLP-1 Suppliers
Imagine two suppliers both advertise research-grade tirzepatide purity at 99%. Supplier A provides a PDF with product name, lot number, HPLC chromatogram, observed mass, theoretical mass, test date, and a clear COA request path for the current lot. Supplier B provides a cropped image that says "99% pure" and a product page with no lot number, no MS data, and no explanation of testing.
The numerical claim is similar, but the procurement risk is not. Supplier A gives a reviewer a record that can be saved, checked, and matched to a vial. Supplier B gives a marketing assertion. A research buyer should prefer traceable documentation over a higher-sounding claim.
The same logic applies to semaglutide. A slightly lower but well-documented purity value can be more credible than an unsupported 99.9% claim. The buyer's job is not to reward the highest number; it is to select a supplier whose records can support reproducible research procurement.
Downloadable Checklist Suggestion
Suggested PDF: GLP-1 Research Peptide COA Verification Checklist.
When requesting documentation, include product name, SKU or selected strength, order number or purchase email, and lot number if available. This helps Vespera match the request to the correct batch record.
Analytical Reference Notes
Analytical quality review for GLP-1 research peptides relies on general chemistry principles. HPLC and UPLC separate components and estimate chromatographic purity. MS and LC-MS support identity through observed mass compared with theoretical mass. Public chemical records such as PubChem Tirzepatide and PubChem Semaglutide can help reviewers cross-check formula and mass context, while batch-specific supplier COAs remain the procurement record. ICH Q2(R2) discusses validation of analytical procedures and performance characteristics such as specificity, accuracy, precision, and range. FDA bioanalytical method validation guidance discusses chromatography and mass spectrometry documentation in regulated analytical work. Supplier COAs for research materials are not regulatory approvals, but they should still be traceable, method-based, and reviewable.
Conclusion
Research-grade GLP-1 peptides require more than a product name and a purity claim. For tirzepatide and semaglutide, credible supplier documentation should show product identity, modified structural information, HPLC or UPLC purity, mass spectrometry confirmation, lot traceability, and a clear COA request path.
In a high-demand market, transparency is the conversion point. Researchers should choose suppliers that make verification straightforward and avoid suppliers that rely on generic PDFs or unsupported "99% pure" language.
A tirzepatide research COA should include product name, SKU, lot number, HPLC or UPLC purity, mass spectrometry identity data, theoretical and observed mass, test date, and lab or supplier document details.
What should semaglutide research peptide specifications show?
Semaglutide specifications should identify the product, modified structure or sequence descriptor, molecular formula or molecular weight basis, purity criteria, identity method, storage label, and batch traceability fields.
Is GLP-1 research peptide documentation different from short peptide documentation?
The core framework is the same, but GLP-1 peptides are more structurally complex. Modified residues, lipidated side chains, and higher market demand make identity and batch verification especially important.
What purity should research-grade tirzepatide show?
Many suppliers list >=98% or >=99% HPLC/UPLC purity. The specific threshold should be supported by a batch COA, method label, and ideally chromatogram.
Is HPLC enough for semaglutide verification?
No. HPLC or UPLC helps estimate purity, but mass spectrometry is needed to support identity confirmation.
What are GLP-1 COA red flags?
Red flags include generic GLP-1 COAs, missing lot numbers, no MS data, no chromatogram, unsupported purity claims, old documents without explanation, and supplier copy that includes dosing or consumer-use claims.
Can I use this article as dosing or protocol guidance?
No. This article is strictly for research procurement and documentation review. It does not provide dosing, administration instructions, medical advice, or consumer-use guidance.
How do I request Vespera GLP-1 COAs?
Use the COA / Specs Request page and include product name, selected strength or SKU, order details, and lot number if available.